/Cas9:

Yajun Shi1,2, Yan Zhao2, Likui Lu2

  • 1Key Laboratory of Birth Defect Prevention and Genetic Medicine of Shandong Health Commission, Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Center for Medical Genetics and Prenatal Diagnosis, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, China.

PubMed
概括

近期在肌缩侧面硬化症 (ALS) 基因组学方面的进展为新疗法铺平了道路. 像CRISPR/Cas9这样的基因编辑工具为开发有效的动物模型和治疗这种毁灭性的神经疾病提供了有希望的途径.